Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

NOVO PUTS UP TO $2.6 BILLION BEHIND HRS-1596: THE OBESITY PILL RACE IS MOVING FROM “ONCE DAILY” TOWARD “ONCE WEEKLY”

29/09/2026 Published by HealthBiz

Key Development A $300 million upfront payment for a candidate only entering Phase 1 suggests Novo Nordisk increasingly sees dosing... Read more

Tags: #Global Trends

HANOI WITHDRAWS 30 MEDICAL-DEVICE DECLARATIONS: POST-MARKET REVIEW IS BECOMING THE REAL GATEKEEPER FOR CLASS A AND B DEVICES

29/09/2026 Published by HealthBiz

Key Development Hanoi's health authority has withdrawn 30 Class A and B medical-device standard declarations. But this should not be... Read more

Category: Uncategorized

Tags: #Vietnam

VIETNAM’S 84 RADIOTHERAPY MACHINES ARE NOT JUST AN EQUIPMENT SHORTAGE — THEY REVEAL A TREATMENT-CAPACITY GAP

29/09/2026 Published by HealthBiz

Key Development Vietnam has roughly 84 linear accelerators serving a cancer system that records more than 180,000 new cases annually.... Read more

Category: Uncategorized

Tags: #Vietnam

ORPATHYS + TAGRISSO FILED WITH FDA: ASTRAZENECA IS TURNING EGFR RESISTANCE INTO A NEW BIOMARKER-DEFINED MARKET

29/09/2026 Published by HealthBiz

Key Development AstraZeneca is not simply adding a MET inhibitor to Tagrisso. It is attempting to extend the treatment life... Read more

Category: Uncategorized

Tags: #Global Trends

VIETNAM’S FIRST FETO PROCEDURE: THE REAL MILESTONE IS NOT ONE FETAL INTERVENTION — IT IS THE EMERGENCE OF A FETAL-THERAPY ECOSYSTEM

29/09/2026 Published by HealthBiz

Key Development On September 26, 2026, Vietnam's National Hospital of Obstetrics and Gynecology reported the country's first technically successful fetoscopic... Read more

Category: Uncategorized

Tags: #Vietnam

PHARMACEUTICAL SELF-RELIANCE: VIETNAM DOES NOT NEED TO MAKE EVERY API — IT NEEDS TO CHOOSE THE RIGHT APIs TO CONTROL

29/09/2026 Published by HealthBiz

Key Development Vietnam's most important pharmaceutical manufacturing gap is increasingly upstream. The country can manufacture finished medicines, but still produces... Read more

Category: Uncategorized

Tags: #Vietnam

BRELOVITUG WINS PHASE 3: THE HDV RACE IS SHIFTING FROM “HAVING A TREATMENT” TO ACHIEVING DEEPER, MORE DURABLE VIRAL CONTROL

29/09/2026 Published by HealthBiz

Key Development Brelovitug has cleared an important Phase 3 hurdle in chronic hepatitis delta — but the market it may... Read more

Category: Uncategorized

Tags: #Global Trends

MERCK PUTS UP TO $2.13 BILLION BEHIND SPR2015: CHINA ONCOLOGY LICENSING IS SHIFTING FROM “CHEAPER ASSETS” TO “EARLY INNOVATION”

29/09/2026 Published by HealthBiz

Key Development The most striking number is not the $2.13 billion headline. It is the $400 million Merck is paying... Read more

Category: Uncategorized

Tags: #Global Trends

MERCK–DAIICHI WITHDRAW I-DXD FILING: THE ERA WHEN A STRONG RESPONSE RATE WAS ENOUGH FOR AN ADC IS FADING

28/09/2026 Published by HealthBiz

Key Development Ifinatamab deruxtecan produced notable responses in one of the most aggressive cancers. But compelling tumor shrinkage and a... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 12 Page 13 Page 14 … Page 224 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members